SEARCH SITE

VIRGINIA LAW PORTAL

SEARCHABLE DATABASES

ACROSS SESSIONS

Developed and maintained by the Division of Legislative Automated Systems.

2012 SESSION

12104689D
HOUSE BILL NO. 399
AMENDMENT IN THE NATURE OF A SUBSTITUTE
(Proposed by the House Committee on Health, Welfare and Institutions
on January 26, 2012)
(Patron Prior to Substitute--Delegate Hope)
A BILL to require the Department of Health to convene a work group to develop a plan for implementation of a program for screening infants for critical congenital cyanotic heart disease.

Be it enacted by the General Assembly of Virginia:

1.  § 1. That the Department of Health shall convene a work group, which shall include, but not be limited to, representatives of the Department of Health, the Department of Health Professions, the Virginia Commonwealth University Health System, the University of Virginia Health System, Eastern Virginia Medical School, the American Heart Association, the Children's National Medical Center, the March of Dimes Virginia Chapter, the Virginia Chapter of the American Academy of Pediatrics, the Virginia Hospital and Healthcare Association, the Medical Society of Virginia, Inova Fairfax Hospital, Carilion Roanoke Memorial Hospital, and the American College of Cardiologists of Virginia, to develop a plan for implementation of a program for screening infants for critical congenital cyanotic heart disease using transcutaneous oxygen monitoring and providing appropriate early intervention services to infants identified as having critical congenital cyanotic heart disease to reduce rates of death or disability among such children. The plan shall include: provisions for implementing the screening program in all hospitals providing maternity services statewide; a process for referring infants identified as having critical congenital cyanotic heart disease to appropriate health care services; provisions for public education regarding the symptoms of critical congenital cyanotic heart disease and options for diagnosis and treatment of critical congenital cyanotic heart disease; and provisions for training health care providers regarding the diagnosis and treatment of critical congenital cyanotic heart disease. The plan shall also include the estimated cost of the program and shall identify potential sources of funding for the program.